Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
WASHINGTON–(BUSINESS WIRE)–#AR—Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that management will be presenting at the upcoming conferences:
Panel Title: New Diagnostics: Revolutionizing Care in Alzheimer’s
Date/Time: Wednesday, Nov. 9, 10:30 – 11:30 am ET
Location: Lotte Palace Hotel, New York, NY
Date: Nov. 13-16, 2022
Location: Kiosk #1158-20, UCSF HealthHub Pavilion, Level 2 show floor, The Venetian Expo & Convention Center, Las Vegas, NV
Panel Title: Digital Phenotypes of Brain Diseases – Transforming Alzheimer’s Disease Drug Development and Disease Management
Date/Time: Saturday, November 19, 1:00 -1:50 pm ET
Location: The Boca Raton, 501 East Camino Real, Boca Raton, FL
Microsoft Data Science & Law Forum
Keynote Title: Transforming patient’s management and clinical development via AI driven precision medicine.
Keynote Speaker: Dr. Antonella Santuccione Chadha, Chief Medical Officer, Altoida
Date: Wednesday, Nov. 23
Location: Brussels, Microsoft HQ
Round table: The Alzheimer’s disease Patient Pathway from a sex and gender lens.
Speaker: Dr. Antonella Santuccione Chadha
Date: Nov. 29 – Dec 2.
Location: Hilton Union Square, San Francisco, CA
Roche Start Up Day
Date: Thursday, Nov. 10
Location: Roche HQ, Basel, Switzerland
Speaker: Dr. Antonella Santuccione Chadha
Digital Phenotypes of Brain Diseases – Transforming neuroscience clinical development
HBA Roche Event
Round table: The missing X
Speaker: Dr. Antonella Santuccione Chadha
Date: Tuesday, Dec. 6
Location: Basel, Roche HQ Switzerland
To meet with the Altoida team at these events, contact bd@altoida.com.
About Altoida, Inc.
Altoida is pioneering precision neurology diagnostics to set a new gold standard for patient care. Our innovative AI-driven approach combines novel digital biomarkers with immersive augmented reality to evaluate cognition. The result is our validated device and evidence-based platform with more than 20 years of scientific research. Altoida is based in Washington, DC. For more information, visit www.altoida.com or follow @Altoida on Twitter.
Contacts
Media
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com
BEIJING, Dec. 4, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the…
LONDON, Dec. 4, 2025 /PRNewswire/ -- self-portrait, the London-based fashion house, is proud to announce that…
Fmr Cash App Design Lead brings nearly two decades of experience leading design and strategy…
Global Games Show 2025 brings together leading game developers, publishers, esports teams, content creators, investors and…
AI-native payments platform enables agents and businesses to onboard and transact directly within their workflows.…
MIAMI, Dec. 4, 2025 /PRNewswire/ -- A new article outlining key considerations for creating effective motion…